The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Natural killer cell biology: An update and future directions
Open accessAbstract
Natural killer (NK) cells constitute a minor subset of normal lymphocytes that initiate innate immune responses toward tumor and virus-infected cells. They can mediate spontaneous cytotoxicity toward these abnormal cells and rapidly secrete numerous cytokines and chemokines to promote subsequent adaptive immune responses. Significant progress has been made in the past two decades to improve our understanding of NK cell biology. Here we review recent discoveries, including a better comprehension of the “education” of NK cells to achieve functional competence during their maturation and the discovery of “memory” responses by NK cells suggesting that they may also contribute to adaptive immunity. The improved understanding of NK cell biology has forged greater awareness that these cells play integral early roles in immune responses. In addition, several promising clinical therapies have been used to exploit NK cell functions in treating cancer patients. As our molecular understanding improves, these and future immunotherapies should continue to provide promising strategies to exploit the unique functions of NK cells to treat cancer, infections, and other pathological conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies
Kohrt, H. E., Houot, R., Goldstein, M. J., Weiskopf, K., Alizadeh, A. A., Brody, J., Müller, A., Pachynski, R., Czerwinski, D., Coutre, S., et al. (2011) · Blood · doi:10.1182/blood-2010-08-301945 · Cited by 205
RetractedFunctions of natural killer cells
Vivier, E., Tomasello, E., Baratin, M., Walzer, T., & Ugolini, S. (2008) · Nature Immunology · doi:10.1038/ni1582 · Cited by 3,943
Chimeric antigen receptor–modified T cells in chronic lymphoid leukemia
Porter, D. L., Levine, B. L., Kalos, M., Bagg, A., & June, C. H. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103849 · Cited by 3,565
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W. D., Tosti, A., Posati, S., Rogaia, D., Frassoni, F., Aversa, F., et al. (2002) · Science · doi:10.1126/science.1068440 · Cited by 3,380
Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999
In search of the ‘missing self’: MHC molecules and NK cell recognition
Ljunggren, H.-G., & Kärre, K. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90097-s · Cited by 2,687 · cited 1×
“(15) The predominant cytolytic targets of NK cells are uncommon cells that have down-regulated class I MHC (MHC-I), which is expressed on nearly every healthy cell of the body.(16) MHC-I loss is a fairly common mechanism by which tumors and virus-infected cells can evade recognition by the TCR of cytolytic T cells,(17…”
Innate lymphoid cells — a proposal for uniform nomenclature
Spits, H., Artis, D., Colonna, M., Diefenbach, A., Di Santo, J. P., Eberl, G., Koyasu, S., Locksley, R. M., McKenzie, A. N. J., Mebius, R. E., et al. (2013) · Nature Reviews Immunology · doi:10.1038/nri3365 · Cited by 2,389
Caligiuri, M. A. (2008) · Blood · doi:10.1182/blood-2007-09-077438 · Cited by 1,905
Miller, J. S., Soignier, Y., Panoskaltsis-Mortari, A., McNearney, S. A., Yun, G. H., Fautsch, S. K., McKenna, D., Le, C., Defor, T. E., Burns, L. J., et al. (2005) · Blood · doi:10.1182/blood-2004-07-2974 · Cited by 1,903
Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R., & Moretta, L. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.197 · Cited by 1,778
Up on the tightrope: natural killer cell activation and inhibition
Lanier, L. L. (2008) · Nature Immunology · doi:10.1038/ni1581 · Cited by 1,656
Adaptive immune features of natural killer cells
Sun, J. C., Beilke, J. N., & Lanier, L. L. (2009) · Nature · doi:10.1038/nature07665 · Cited by 1,619
Kochenderfer, J. N., Dudley, M. E., Feldman, S. A., Wilson, W. H., Spaner, D. E., Maric, I., Stetler-Stevenson, M., Phan, G. Q., Hughes, M. S., Sherry, R. M., et al. (2012) · Blood · doi:10.1182/blood-2011-10-384388 · Cited by 1,440
Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming
Martín-Fontecha, A., Thomsen, L. L., Brett, S., Gerard, C., Lipp, M., Lanzavecchia, A., & Sallusto, F. (2004) · Nature Immunology · doi:10.1038/ni1138 · Cited by 1,353
Licensing of natural killer cells by host major histocompatibility complex class I molecules
Kim, S., Poursine-Laurent, J., Truscott, S. M., Lybarger, L., Song, Y.-J., Yang, L., French, A. R., Sunwoo, J. B., Lemieux, S., Hansen, T. H., et al. (2005) · Nature · doi:10.1038/nature03847 · Cited by 1,340
Brentjens, R. J., Rivière, I., Park, J. H., Davila, M. L., Wang, X., Stefanski, J., Taylor, C., Yeh, R., Bartido, S., Borquez-Ojeda, O., et al. (2011) · Blood · doi:10.1182/blood-2011-04-348540 · Cited by 1,286
Human NK Cell Education by Inhibitory Receptors for MHC Class I
Anfossi, N., André, P., Guia, S., Falk, C. S., Roetynck, S., Stewart, C. A., Breso, V., Frassati, C., Reviron, D., Middleton, D., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.06.013 · Cited by 1,211
MHC class I molecules and kirs in human history, health and survival
Parham, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1570 · Cited by 1,203
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS
Martin, M. P., Gao, X., Lee, J.-H., Nelson, G. W., Detels, R., Goedert, J. J., Buchbinder, S., Hoots, K., Vlahov, D., Trowsdale, J., et al. (2002) · Nature Genetics · doi:10.1038/ng934 · Cited by 1,189
HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection
Khakoo, S. I., Thio, C. L., Martin, M. P., Brooks, C. R., Gao, X., Astemborski, J., Cheng, J., Goedert, J. J., Vlahov, D., Hilgartner, M., et al. (2004) · Science · doi:10.1126/science.1097670 · Cited by 1,179
Hiby, S. E., Walker, J. J., O'Shaughnessy, K. M., Redman, C. W. G., Carrington, M., Trowsdale, J., & Moffett, A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041214 · Cited by 1,121
Role of Natural Killer Cell Alloreactivity in HLA-Mismatched Hematopoietic Stem Cell Transplantation
Ruggeri, L., Capanni, M., Casucci, M., Volpi, I., Tosti, A., Perruccio, K., Urbani, E., Negrin, R. S., Martelli, M. F., & Velardi, A. (1999) · Blood · doi:10.1182/blood.v94.1.333.413a31_333_339 · Cited by 994
KIR: Diverse, Rapidly Evolving Receptors of Innate and Adaptive Immunity
Vilches, C., & Parham, P. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.092501.134942 · Cited by 986
T cell– and B cell–independent adaptive immunity mediated by natural killer cells
O'Leary, J. G., Goodarzi, M., Drayton, D. L., & von Andrian, U. H. (2006) · Nature Immunology · doi:10.1038/ni1332 · Cited by 919
Regulation of human NK-cell cytokine and chemokine production by target cell recognition
Fauriat, C., Long, E. O., Ljunggren, H.-G., & Bryceson, Y. T. (2010) · Blood · doi:10.1182/blood-2009-08-238469 · Cited by 891
Fehniger, T. A., Cooper, M. A., Nuovo, G. J., Cella, M., Facchetti, F., Colonna, M., & Caligiuri, M. A. (2003) · Blood · doi:10.1182/blood-2002-09-2876 · Cited by 857
Cytokine-induced memory-like natural killer cells
Cooper, M. A., Elliott, J. M., Keyel, P. A., Yang, L., Carrero, J. A., & Yokoyama, W. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813192106 · Cited by 831
Lopez-Vergès, S., Milush, J. M., Schwartz, B. S., Pando, M. J., Jarjoura, J., York, V. A., Houchins, J. P., Miller, S., Kang, S.-M., Norris, P. J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110900108 · Cited by 822
Benson, D. M., Bakan, C. E., Mishra, A., Hofmeister, C. C., Efebera, Y., Becknell, B., Baiocchi, R. A., Zhang, J., Yu, J., Smith, M. K., et al. (2010) · Blood · doi:10.1182/blood-2010-02-271874 · Cited by 807
Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
Chen, D., Frezza, M., Schmitt, S., Kanwar, J., & P. Dou, Q. (2011) · Current Cancer Drug Targets · doi:10.2174/156800911794519752 · Cited by 795
Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1
Martin, M. P., Qi, Y., Gao, X., Yamada, E., Martin, J. N., Pereyra, F., Colombo, S., Brown, E. E., Shupert, W. L., Phair, J., et al. (2007) · Nature Genetics · doi:10.1038/ng2035 · Cited by 750
CD27 Dissects Mature NK Cells into Two Subsets with Distinct Responsiveness and Migratory Capacity
Hayakawa, Y., & Smyth, M. J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1517 · Cited by 749
Valiante, N. M., Uhrberg, M., Shilling, H. G., Lienert-Weidenbach, K., Arnett, K. L., D'Andrea, A., Phillips, J. H., Lanier, L. L., & Parham, P. (1997) · Immunity · doi:10.1016/s1074-7613(00)80393-3 · Cited by 732
Brandt, C. S., Baratin, M., Yi, E. C., Kennedy, J., Gao, Z., Fox, B., Haldeman, B., Ostrander, C. D., Kaifu, T., Chabannon, C., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090681 · Cited by 706
Paust, S., Gill, H. S., Wang, B.-Z., Flynn, M. P., Moseman, E. A., Senman, B., Szczepanik, M., Telenti, A., Askenase, P. W., Compans, R. W., et al. (2010) · Nature Immunology · doi:10.1038/ni.1953 · Cited by 694
Cytokine activation induces human memory-like NK cells
Romee, R., Schneider, S. E., Leong, J. W., Chase, J. M., Keppel, C. R., Sullivan, R. P., Cooper, M. A., & Fehniger, T. A. (2012) · Blood · doi:10.1182/blood-2012-04-419283 · Cited by 684
Innate lymphoid cells — how did we miss them?
Walker, J. A., Barlow, J. L., & McKenzie, A. N. J. (2013) · Nature Reviews Immunology · doi:10.1038/nri3349 · Cited by 669
Imai, C., Iwamoto, S., & Campana, D. (2005) · Blood · doi:10.1182/blood-2004-12-4797 · Cited by 659
Rubnitz, J. E., Inaba, H., Ribeiro, R. C., Pounds, S., Rooney, B., Bell, T., Pui, C.-H., & Leung, W. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.4590 · Cited by 649
Foley, B., Cooley, S., Verneris, M. R., Pitt, M., Curtsinger, J., Luo, X., Lopez-Vergès, S., Lanier, L. L., Weisdorf, D., & Miller, J. S. (2012) · Blood · doi:10.1182/blood-2011-10-386995 · Cited by 630
Self-tolerance of natural killer cells
Raulet, D. H., & Vance, R. E. (2006) · Nature Reviews Immunology · doi:10.1038/nri1863 · Cited by 608
Natural killer cells act as rheostats modulating antiviral T cells
Waggoner, S. N., Cornberg, M., Selin, L. K., & Welsh, R. M. (2012) · Nature · doi:10.1038/nature10624 · Cited by 607
Cooley, S., Weisdorf, D. J., Guethlein, L. A., Klein, J. P., Wang, T., Le, C. T., Marsh, S. G. E., Geraghty, D., Spellman, S., Haagenson, M. D., et al. (2010) · Blood · doi:10.1182/blood-2010-05-283051 · Cited by 591
Fernandez, N. C., Treiner, E., Vance, R. E., Jamieson, A. M., Lemieux, S., & Raulet, D. H. (2005) · Blood · doi:10.1182/blood-2004-08-3156 · Cited by 588
Béziat, V., Liu, L. L., Malmberg, J.-A., Ivarsson, M. A., Sohlberg, E., Björklund, A. T., Retière, C., Sverremark-Ekström, E., Traherne, J., Ljungman, P., et al. (2013) · Blood · doi:10.1182/blood-2012-10-459545 · Cited by 512
MHC Class I Deficiency: Susceptibility to Natural Killer (NK) Cells and Impaired NK Activity
Liao, N.-S., Bix, M., Zijlstra, M., Jaenisch, R., & Raulet, D. (1991) · Science · doi:10.1126/science.1853205 · Cited by 490
Björkström, N. K., Lindgren, T., Stoltz, M., Fauriat, C., Braun, M., Evander, M., Michaëlsson, J., Malmberg, K.-J., Klingström, J., Ahlm, C., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20100762 · Cited by 479
Arai, S., Meagher, R., Swearingen, M., Myint, H., Rich, E., Martinson, J., & Klingemann, H. (2008) · Cytotherapy · doi:10.1080/14653240802301872 · Cited by 434
HLA-C–Dependent Prevention of Leukemia Relapse by Donor Activating KIR2DS1
Venstrom, J. M., Pittari, G., Gooley, T. A., Chewning, J. H., Spellman, S., Haagenson, M., Gallagher, M. M., Malkki, M., Petersdorf, E., Dupont, B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200503 · Cited by 429
Sustained effector function of IL-12/15/18–preactivated NK cells against established tumors
Ni, J., Miller, M., Stojanovic, A., Garbi, N., & Cerwenka, A. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120944 · Cited by 419
Romagné, F., André, P., Spee, P., Zahn, S., Anfossi, N., Gauthier, L., Capanni, M., Ruggeri, L., Benson, D. M., Blaser, B. W., et al. (2009) · Blood · doi:10.1182/blood-2009-02-206532 · Cited by 408
Curti, A., Ruggeri, L., D'Addio, A., Bontadini, A., Dan, E., Motta, M. R., Trabanelli, S., Giudice, V., Urbani, E., Martinelli, G., et al. (2011) · Blood · doi:10.1182/blood-2011-01-329508 · Cited by 406
De Maria, A., Bozzano, F., Cantoni, C., & Moretta, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012356108 · Cited by 344
Hayashi, T., Hideshima, T., Akiyama, M., Podar, K., Yasui, H., Raje, N., Kumar, S., Chauhan, D., Treon, S. P., Richardson, P., et al. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05286.x · Cited by 323
Proinflammatory cytokine signaling required for the generation of natural killer cell memory
Sun, J. C., Madera, S., Bezman, N. A., Beilke, J. N., Kaplan, M. H., & Lanier, L. L. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111760 · Cited by 302
Joncker, N. T., Fernandez, N. C., Treiner, E., Vivier, E., & Raulet, D. H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803900 · Cited by 291
NK cell education: not an on-off switch but a tunable rheostat
Brodin, P., Kärre, K., & Höglund, P. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.01.006 · Cited by 288
Miller, J. S., Cooley, S., Parham, P., Farag, S. S., Verneris, M. R., McQueen, K. L., Guethlein, L. A., Trachtenberg, E. A., Haagenson, M., Horowitz, M. M., et al. (2007) · Blood · doi:10.1182/blood-2007-01-065383 · Cited by 288
Brodin, P., Lakshmikanth, T., Johansson, S., Kärre, K., & Höglund, P. (2009) · Blood · doi:10.1182/blood-2008-05-156836 · Cited by 279
A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission
Vey, N., Bourhis, J.-H., Boissel, N., Bordessoule, D., Prebet, T., Charbonnier, A., Etienne, A., Andre, P., Romagne, F., Benson, D., et al. (2012) · Blood · doi:10.1182/blood-2012-06-437558 · Cited by 278
'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection
Orr, M. T., Murphy, W. J., & Lanier, L. L. (2010) · Nature Immunology · doi:10.1038/ni.1849 · Cited by 276
Uherek, C., Tonn, T., Uherek, B., Becker, S., Schnierle, B., Klingemann, H.-G., & Wels, W. (2002) · Blood · doi:10.1182/blood.v100.4.1265.h81602001265_1265_1273 · Cited by 262
HLA alleles determine differences in human natural killer cell responsiveness and potency
Kim, S., Sunwoo, J. B., Yang, L., Choi, T., Song, Y.-J., French, A. R., Vlahiotis, A., Piccirillo, J. F., Cella, M., Colonna, M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712229105 · Cited by 259
Koka, R., Burkett, P. R., Chien, M., Chai, S., Chan, F., Lodolce, J. P., Boone, D. L., & Ma, A. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021836 · Cited by 252
Benson, D. M., Hofmeister, C. C., Padmanabhan, S., Suvannasankha, A., Jagannath, S., Abonour, R., Bakan, C., Andre, P., Efebera, Y., Tiollier, J., et al. (2012) · Blood · doi:10.1182/blood-2012-06-438028 · Cited by 244
In Vivo Survival and Homeostatic Proliferation of Natural Killer Cells
Prlic, M., Blazar, B. R., Farrar, M. A., & Jameson, S. C. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021847 · Cited by 243
Natural killer cell-triggered vascular transformation: maternal care before birth?
Zhang, J., Chen, Z., Smith, G. N., & Croy, B. A. (2011) · Cellular & Molecular Immunology · doi:10.1038/cmi.2010.38 · Cited by 237
Seidel, U. J. E., Schlegel, P., & Lang, P. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00076 · Cited by 236
Human NK cell lytic granules and regulation of their exocytosis
Krzewski, K., & Coligan, J. E. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00335 · Cited by 229
Human natural killer cell deficiencies
Orange, J. S. (2006) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e3280106b65 · Cited by 229
Cooley, S., Xiao, F., Pitt, M., Gleason, M., McCullar, V., Bergemann, T. L., McQueen, K. L., Guethlein, L. A., Parham, P., & Miller, J. S. (2007) · Blood · doi:10.1182/blood-2006-07-036228 · Cited by 226
Raulet, D. H., Held, W., Correa, I., Dorfman, J. R., Wu, M., & Corral, L. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb00938.x · Cited by 224
Müller, T., Uherek, C., Maki, G., Chow, K. U., Schimpf, A., Klingemann, H.-G., Tonn, T., & Wels, W. S. (2008) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-007-0383-3 · Cited by 212
Benson, D. M., Bakan, C. E., Zhang, S., Collins, S. M., Liang, J., Srivastava, S., Hofmeister, C. C., Efebera, Y., Andre, P., Romagne, F., et al. (2011) · Blood · doi:10.1182/blood-2011-06-360255 · Cited by 208
Altvater, B., Landmeier, S., Pscherer, S., Temme, J., Schweer, K., Kailayangiri, S., Campana, D., Juergens, H., Pule, M., & Rossig, C. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2810 · Cited by 206
NK cells: a lesson from mismatched hematopoietic transplantation
Velardi, A., Ruggeri, L., Alessandro, Moretta, & Moretta, L. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02284-6 · Cited by 199
Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B
Vivian, J. P., Duncan, R. C., Berry, R., O’Connor, G. M., Reid, H. H., Beddoe, T., Gras, S., Saunders, P. M., Olshina, M. A., Widjaja, J. M. L., et al. (2011) · Nature · doi:10.1038/nature10517 · Cited by 194
Turnover and Proliferation of NK Cells in Steady State and Lymphopenic Conditions
Jamieson, A. M., Isnard, P., Dorfman, J. R., Coles, M. C., & Raulet, D. H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.864 · Cited by 180
Binyamin, L., Alpaugh, R. K., Hughes, T. L., Lutz, C. T., Campbell, K. S., & Weiner, L. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.6392 · Cited by 176
Self-citationZhu, D., Corral, L. G., Fleming, Y. W., & Stein, B. (2008) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-008-0512-7 · Cited by 164
Hsu, A. K., Quach, H., Tai, T., Prince, H. M., Harrison, S. J., Trapani, J. A., Smyth, M. J., Neeson, P., & Ritchie, D. S. (2011) · Blood · doi:10.1182/blood-2010-04-278432 · Cited by 158
Chalifour, A., Scarpellino, L., Back, J., Brodin, P., Devêvre, E. F., Gros, F., Lévy, F., Leclercq, G., Höglund, P., Beermann, F., et al. (2009) · Immunity · doi:10.1016/j.immuni.2008.12.019 · Cited by 154
Copy Number Variation of KIR Genes Influences HIV-1 Control
Pelak, K., Need, A. C., Fellay, J., Shianna, K. V., Feng, S., Urban, T. J., Ge, D., Luca, A. D., Martínez‐Picado, J., Wolinsky, S. M., et al. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001208 · Cited by 149
Sun, J. C.-Y., Beilke, J. N., Bezman, N., & Lanier, L. L. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20100479 · Cited by 146
Li, L., Liu, L. N., Feller, S., Allen, C., Shivakumar, R., Fratantoni, J. C., Wolfraim, L. A., Fujisaki, H., Campana, D., Chopas, N., et al. (2009) · Cancer Gene Therapy · doi:10.1038/cgt.2009.61 · Cited by 144
McQueen, K. L., Dorighi, K. M., Guethlein, L. A., Wong, R. M., Sanjanwala, B. M., & Parham, P. (2007) · Human Immunology · doi:10.1016/j.humimm.2007.01.019 · Cited by 141
The Bidirectional Crosstalk between Human Dendritic Cells and Natural Killer Cells
Wehner, R., Dietze, K., Bachmann, M. P., & Schmitz, M. (2011) · Journal of Innate Immunity · doi:10.1159/000323923 · Cited by 134
The ever‐expanding Ly49 gene family: repertoire and signaling
Anderson, S. K., Ortaldo, J. R., & McVicar, D. W. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1810106.x · Cited by 131
Schönberg, K., Sribar, M., Enczmann, J., Fischer, J., & Uhrberg, M. (2011) · Blood · doi:10.1182/blood-2010-03-273656 · Cited by 129
Saleh, A., Davies, G., Pascal, V., Wright, P. W., Hodge, D., Cho, E., Lockett, S., Abshari, M., & Anderson, S. (2004) · Immunity · doi:10.1016/j.immuni.2004.06.005 · Cited by 128
Seliger, B., Ritz, U., & Ferrone, S. (2005) · International Journal of Cancer · doi:10.1002/ijc.21312 · Cited by 122
Fang, M., Roscoe, F., & Sigal, L. J. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20100282 · Cited by 122
Signal Transduction in Natural Killer Cells
Macfarlane, A. W., & Campbell, K. S. (2005) · Current topics in microbiology and immunology · doi:10.1007/3-540-27743-9_2 · Cited by 110
Self-citationStringaris, K., Adams, S., Uribe, M. R., Eniafe, R., Wu, C. O., Savani, B., & Barrett, A. (2010) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2010.03.004 · Cited by 97
Viral evasion of T cell immunity: ancient mechanisms offering new applications
Horst, D., Verweij, M. C., Davison, A. J., Ressing, M. E., & Wiertz, E. J. H. J. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.11.005 · Cited by 96
Groß, C. C., Brzostowski, J. A., Liu, D., & Long, E. O. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000761 · Cited by 95
Crosstalk between neutrophils and dendritic cells: a context-dependent process
Schuster, S., Hurrell, B. P., & Tacchini‐Cottier, F. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.1012540 · Cited by 92
Lundqvist, A., Yokoyama, H., Smith, A. L., Berg, M., & Childs, R. W. (2009) · Blood · doi:10.1182/blood-2008-11-190421 · Cited by 91
Mace, E. M., Zhang, J., Siminovitch, K. A., & Takei, F. (2010) · Blood · doi:10.1182/blood-2009-12-261487 · Cited by 89
Natural killer cells: a review of manufacturing and clinical utility
Koepsell, S. A., Miller, J. S., & McKenna, D. H. (2012) · Transfusion · doi:10.1111/j.1537-2995.2012.03724.x · Cited by 88
Armeanu, S., Krusch, M., Baltz, K. M., Weiß, T. S., Smirnow, I., Steinle, A., Lauer, U. M., Bitzer, M., & Salih, H. R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4744 · Cited by 85
Haas, P., Loiseau, P., Tamouza, R., Cayuela, J., Moins‐Teisserenc, H., Busson, M., Henry, G., Falk, C. S., Charron, D. J., Socié, G., et al. (2010) · Blood · doi:10.1182/blood-2010-02-269381 · Cited by 77
Genetic and antibody-mediated reprogramming of natural killer cell missing-self recognition in vivo
Sola, C., André, P., Lemmers, C., Fuséri, N., Bonnafous, C., Bléry, M., Wagtmann, N. R., Romagné, F., Vivier, É., & Ugolini, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901653106 · Cited by 73
Brown, A. C. N., Dobbie, I. M., Alakoskela, J.-M. I., Davis, I., & Davis, D. M. (2012) · Blood · doi:10.1182/blood-2012-05-429977 · Cited by 71
Identification of bidirectional promoters in the human KIR genes
Davies, G. E., Locke, S., Wright, P. W., Li, H., Hanson, R. J., Miller, J. S., & Anderson, S. K. (2007) · Genes and Immunity · doi:10.1038/sj.gene.6364381 · Cited by 71
Lundqvist, A., Berg, M., Smith, A. L., & Childs, R. W. (2011) · Journal of Cancer · doi:10.7150/jca.2.383 · Cited by 70
Cutting Edge: KIR Antisense Transcripts Are Processed into a 28-Base PIWI-Like RNA in Human NK Cells
Cichocki, F. M., Lenvik, T. R., Sharma, N., Yun, G. H., Anderson, S. K., & Miller, J. S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000855 · Cited by 67
Molecular Action of Lenalidomide in Lymphocytes and Hematologic Malignancies
McDaniel, J. M., Pinilla-Ibarz, J. A., & Epling‐Burnette, P. K. (2012) · Advances in Hematology · doi:10.1155/2012/513702 · Cited by 64
Novel immune modulators used in hematology: impact on NK cells
Krieg, S., & Ullrich, E. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00388 · Cited by 55
Korbel, D. S., Norman, P. J., Newman, K. C., Horowitz, A., Gendzekhadze, K., Parham, P., & Riley, E. M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804224 · Cited by 47
Klingemann, H., Grodman, C., Cutler, E., Duque, M., Kadidlo, D. M., Klein, A., Sprague, K. A., Miller, K. B., Comenzo, R., Kewalramani, T., et al. (2012) · Transfusion · doi:10.1111/j.1537-2995.2012.03764.x · Cited by 46
Analysis of Binding of KIR3DS1*014 to HLA Suggests Distinct Evolutionary History of KIR3DS1
O’Connor, G. M., Yamada, E., Rampersaud, A., Thomas, R., Carrington, M. N., & McVicar, D. W. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002906 · Cited by 32
Cited by
Engineering Natural Killer Cells for Cancer Immunotherapy
Rezvani, K., Rouce, R., Liu, E., & Shpall, E. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.06.012 · Cited by 453
Immunometabolism and natural killer cell responses
O’Brien, K. L., & Finlay, D. K. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0139-2 · Cited by 435
Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities
Hu, W., Wang, G., Huang, D., Sui, M., & Xu, Y. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01205 · Cited by 398
The role of cytokines in the regulation of NK cells in the tumor environment
Konjević, G. M., Vuletić, A. M., Mirjačić Martinović, K. M., Larsen, A. K., & Jurišić, V. B. (2019) · Cytokine · doi:10.1016/j.cyto.2019.02.001 · Cited by 279
The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer
Rezvani, K., & Rouce, R. H. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00578 · Cited by 272
Metadata
- Authors
- Campbell, K. S., & Hasegawa, J.
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2013-09
- Volume
- 132
- Issue
- 3
- Pages
- 536-544
- ISSN
- 0091-6749 (ISSN-L)
- OpenAlex
- W2015912224
- Cited by
- 416
- References
- 112
- FWCI
- 16.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.